IMMUNOVANT, INC. Shares Outstanding (Cover Page)
IMMUNOVANT, INC. (IMVT) had Shares Outstanding (Cover Page) of 206.55 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 206.55M shares.
- 2026-05-14: Entity Common Stock, Shares Outstanding 205.31M shares.
- 2026-02-02: Entity Common Stock, Shares Outstanding 203.53M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 175.28M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 206.55M shares 10-Q · filed 2026-08-06 |
| 2026-05-14 | 205.31M shares 10-K · filed 2026-05-20 |
| 2026-02-02 | 203.53M shares 10-Q · filed 2026-02-06 |
| 2025-11-03 | 175.28M shares 10-Q · filed 2025-11-10 |
| 2025-08-04 | 174.32M shares 10-Q · filed 2025-08-11 |
| 2025-05-23 | 170.92M shares 10-K · filed 2025-05-29 |
| 2025-01-31 | 169.86M shares 10-Q · filed 2025-02-06 |
| 2024-11-01 | 146.78M shares 10-Q · filed 2024-11-07 |
| 2024-07-30 | 146.37M shares 10-Q · filed 2024-08-06 |
| 2024-05-22 | 146.05M shares 10-K · filed 2024-05-29 |
| 2024-02-05 | 145.29M shares 10-Q · filed 2024-02-12 |
| 2023-11-03 | 144.66M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 130.67M shares 10-Q · filed 2023-08-10 |
| 2023-05-17 | 130.41M shares 10-K · filed 2023-05-22 |
| 2023-01-27 | 130.25M shares 10-Q · filed 2023-02-03 |
| 2022-10-28 | 129.18M shares 10-Q · filed 2022-11-04 |
| 2022-07-29 | 116.58M shares 10-Q · filed 2022-08-05 |
| 2022-06-03 | 116.51M shares 10-K · filed 2022-06-08 |
| 2022-02-01 | 116.40M shares 10-Q · filed 2022-02-04 |
| 2021-11-01 | 115.00M shares 10-Q · filed 2021-11-05 |
| 2021-08-09 | 115.00M shares 10-Q · filed 2021-08-09 |
| 2021-06-01 | 97.98M shares 10-K · filed 2021-06-01 |
| 2021-02-16 | 97.97M shares 10-Q · filed 2021-02-16 |
| 2020-11-12 | 97.89M shares 10-Q · filed 2020-11-12 |
| 2020-08-12 | 81.81M shares 10-Q · filed 2020-08-12 |
| 2020-06-29 | 81.81M shares 10-K · filed 2020-06-29 |
| 2020-02-14 | 56.46M shares 10-Q · filed 2020-02-14 |
| 2019-11-13 | 14.38M shares 10-Q · filed 2019-11-13 |
| 2019-08-12 | 14.38M shares 10-Q · filed 2019-08-12 |
| 2019-06-12 | 14.38M shares 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |